Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monoclonal Antibody MG96 Completely Blocks <i>Plasmodium yoelii</i> Developmentin <i>Anophelesstephensi</i>

25 Nov 2003

Abstract excerpt

In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive. The predominant vaccine strategy focuses on targeting parasite blood stages in the vertebrate host. An alternative approach has been the development of transmission-blocking vaccines (TBVs). TBVs target antigens on parasite sexual stages that persist within the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Invertebrate Immune Response Mechanisms
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14638789
DOI: 10.1128/iai.71.12.6995-7001.2003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monoclonal Antibody MG96 Completely Blocks <i>Plasmodium yoelii</i> Developmentin <i>Anophelesstephensi</i>PMID 14638789Read ↗

Toward the development of effective transmission-blocking vaccines for malariaSemantic proximity Read ↗

Disruption of the AgMOBP1–PfSyn5 interface abolishes malaria transmissionSemantic proximity Read ↗

<i>Plasmodium</i> P25 and P28 Surface Proteins: Potential Transmission-Blocking VaccinesSemantic proximity Read ↗

Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine CandidatesSemantic proximity Read ↗

Multi-protein chimeric antigens, a novel combined approach for efficiently targeting and blocking the blood stage of <i>Plasmodium falciparum</i>Semantic proximity Read ↗

Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.Semantic proximity Read ↗

<i>Plasmodium</i> PIMMS43 is required for ookinete evasion of the mosquito complement-like response and sporogonic development in the oocystSemantic proximity Read ↗

A high affinity human monoclonal antibody against Pfs230 binds multiple parasite stages and blocks oocyst formation in mosquitoesSemantic proximity Read ↗

Carboxypeptidases B of Anopheles gambiae as Targets for a Plasmodium falciparum Transmission-Blocking VaccineSemantic proximity Read ↗

Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant VaccineSemantic proximity Read ↗

Pfs48/45 nanobodies block <i>Plasmodium falciparum</i> transmissionSemantic proximity Read ↗

Comparative and functional genomics of the innate immune system in the malaria vector <i>Anopheles gambiae</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.